Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Agios Pharmaceuticals Inc (NASDAQ:AGIO)

54.21
Delayed Data
As of Sep 28
 -0.34 / -0.62%
Today’s Change
33.50
Today|||52-Week Range
81.77
-16.50%
Year-to-Date
No recent news for Agios Pharmaceuticals Inc.

Today’s Trading

Previous close54.55
Today’s open54.65
Day’s range52.38 - 54.99
Volume546,832
Average volume (3 months)784,018
Market cap$2.3B
Dividend yield--
Data as of 4:14pm ET, 09/28/2016

Growth & Valuation

Earnings growth (last year)-98.11%
Earnings growth (this year)-53.81%
Earnings growth (next 5 years)--
Revenue growth (last year)-9.55%
P/E ratioNM
Price/Sales41.10
Price/Book5.96

Competitors

 Today’s
change
Today’s
% change
PBYIPuma Biotechnology I...-3.15-4.47%
IRWDIronwood Pharmaceuti...-0.22-1.37%
PRTAProthena Corporation...-1.64-2.60%
OPHTOphthotech Corp-1.08-1.85%
Data as of 4:01pm ET, 09/28/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$1.53
Annual revenue (last year)$59.1M
Annual profit (last year)-$117.7M
Net profit margin-199.14%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David Paul Schenkein
Chief Financial Officer
Andrew J. Hirsch
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Search for Jobs